Kalvista Pharmaceuticals Inc KALV:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
Last | 1:02 PM EDT
11.51quote price arrow up+0.01 (+0.09%)
Volume
103,271
52 week range
7.21 - 16.88
Loading...
  • Open11.42
  • Day High11.78
  • Day Low11.42
  • Prev Close11.50
  • 52 Week High16.88
  • 52 Week High Date02/01/24
  • 52 Week Low7.21
  • 52 Week Low Date11/13/23

Key Stats

  • Market Cap485.587M
  • Shares Out42.19M
  • 10 Day Average Volume0.36M
  • Dividend-
  • Dividend Yield-
  • Beta0.91
  • YTD % Change-6.37

KEY STATS

  • Open11.42
  • Day High11.78
  • Day Low11.42
  • Prev Close11.50
  • 52 Week High16.88
  • 52 Week High Date02/01/24
  • 52 Week Low7.21
  • 52 Week Low Date11/13/23
  • Market Cap485.587M
  • Shares Out42.19M
  • 10 Day Average Volume0.36M
  • Dividend-
  • Dividend Yield-
  • Beta0.91
  • YTD % Change-6.37

RATIOS/PROFITABILITY

  • EPS (TTM)-3.14
  • P/E (TTM)-3.66
  • Fwd P/E (NTM)-4.32
  • EBITDA (TTM)-122.933M
  • ROE (TTM)-79.33%
  • Revenue (TTM)-
  • Gross Margin (TTM)-
  • Net Margin (TTM)-990.38%
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date07/05/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Kalvista Pharmaceuticals Inc

 

Profile

MORE
KalVista Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. The Company is focused on the discovery, development and commercialization of small molecule protease inhibitors for diseases with unmet need. The Company has developed a portfolio of small molecule plasma kallikrein inhibitors targeting the disease hereditary angioedema (HAE). The Company is developing sebetralstat as an oral on-demand therapy for HAE attacks and has achieved target enrollment for the...
Brian Pereira M.D.
Independent Non-Executive Chairman of the Board
Benjamin Palleiko
Chief Executive Officer, Director
Address
55 Cambridge Pkwy Ste 901E
Cambridge, MA
02142-1234
United States

Top Peers

SYMBOLLASTCHG%CHG
TRML
Tourmaline Bio Inc
15.49-0.17-1.10%
LXRX
Lexicon Pharmaceuticals Inc
1.67+0.04+2.15%
SLRN
ACELYRIN Inc
4.84-0.04-0.82%
LBPH
Longboard Pharmaceuticals Inc
18.38+0.37+2.05%
THRD
Third Harmonic Bio Inc
11.46+0.03+0.26%